News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018
News Daily News Edoxaban Looks Good for Asians With A-fib in Real-world Analysis Todd Neale August 14, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Daily News Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval Michael O'Riordan May 01, 2018
News Conference News ACC 2018 Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4 Todd Neale March 13, 2018
News Conference News ACC 2018 Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis Todd Neale March 12, 2018
News Daily News NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin L.A. McKeown January 02, 2018